| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
D-Pharm LTD (TA: DPRM)
DPRM Technical Analysis
5
| As on 15th Dec 2022 DPRM STOCK Price closed @ 9.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 216.18 & Strong Sell for SHORT-TERM with Stoploss of 266.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DPRMSTOCK Price
| Open | 10.00 | Change | Price | % |
| High | 10.00 | 1 Day | -0.50 | -5.05 |
| Low | 9.00 | 1 Week | -4.10 | -30.37 |
| Close | 9.40 | 1 Month | -21.40 | -69.48 |
| Volume | 197331 | 1 Year | -244.70 | -96.30 |
| 52 Week High 312.00 | 52 Week Low 12.10 | ||||
TA Israel Most Active Stocks
| TA125 | 2008.05 | 1.06% |
| ORL | 92.30 | -5.04% |
| BLRX | 10.50 | -25.00% |
| CANF | 2.60 | -3.70% |
| BEZQ | 520.00 | -2.71% |
| ELAL | 846.50 | 1.46% |
| LUMI | 4135.00 | 1.67% |
| ICL | 1689.00 | 2.80% |
| POLI | 4210.00 | 2.13% |
| DSCT | 2394.00 | 1.79% |
TA Israel Top Gainers Stocks
TA Israel Top Losers Stocks
| DPRM Daily Charts |
DPRM Intraday Charts |
Whats New @ Bazaartrend |
DPRM Free Analysis |
|
|
DPRM Important Levels Intraday
| RESISTANCE | 11.33 |
| RESISTANCE | 10.71 |
| RESISTANCE | 10.33 |
| RESISTANCE | 9.95 |
| SUPPORT | 8.86 |
| SUPPORT | 8.47 |
| SUPPORT | 8.09 |
| SUPPORT | 7.47 |
DPRM Forecast November 2024
| 4th UP Forecast | 175.7 |
| 3rd UP Forecast | 122.37 |
| 2nd UP Forecast | 89.4 |
| 1st UP Forecast | 56.43 |
| 1st DOWN Forecast | -37.63 |
| 2nd DOWN Forecast | -70.6 |
| 3rd DOWN Forecast | -103.57 |
| 4th DOWN Forecast | -156.9 |
DPRM Weekly Forecast
| 4th UP Forecast | 91.10 |
| 3rd UP Forecast | 64.90 |
| 2nd UP Forecast | 48.70 |
| 1st UP Forecast | 32.51 |
| 1st DOWN Forecast | -13.71 |
| 2nd DOWN Forecast | -29.90 |
| 3rd DOWN Forecast | -46.10 |
| 4th DOWN Forecast | -72.30 |
DPRM Forecast2024
| 4th UP Forecast | 608.7 |
| 3rd UP Forecast | 416.5 |
| 2nd UP Forecast | 297.7 |
| 1st UP Forecast | 178.9 |
| 1st DOWN Forecast | -160.1 |
| 2nd DOWN Forecast | -278.9 |
| 3rd DOWN Forecast | -397.7 |
| 4th DOWN Forecast | -589.9 |
D-Pharm LTD ( TA Israel Symbol : DPRM )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
DPRM Business Profile
D-Pharm LTD., a drug-development company, focuses on the development of drugs for the treatment of central nervous system conditions. Its product portfolio includes three clinical Phase 2 drug-candidates addressing unmet needs: THR-18 for safe thrombolysis to restore blood flow to the brain, heart, or lungs; DP-VPA for the treatment of epilepsy, migraine, and manic depression; and DP-b99 for protection of cells under stress in acute pancreatitis. D-Pharm LTD. was founded in 1993 and is based in Rehovot, Israel. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service